Mr. Willie has served as Vice President, Finance of Palisade Bio since January of 2022. Mr. Willie joined the company as Controller in June 2018 and served as Director of Finance and Controller from April 2019 to December 2021 where he played an instrumental role in the execution of the company’s 2021 merger with Leading BioSciences, resulting in Palisade Bio’s public listing on the Nasdaq Capital Market. Prior to joining Palisade Bio, Mr. Willie held various senior roles at PricewaterhouseCoopers, LLP where he provided key assurance services to clinical-stage biotechnology companies as they navigated the complexities of international collaborations, clinical trials, and follow-on offerings.

Mr. Willie earned a Master’s degree in accountancy and bachelor’s degree in accounting from Brigham Young University and is a Certified Public Accountant (inactive) in the state of California.